8-KEarnings & ResultsExhibits & Filings

ABBOTT LABORATORIES 8-K Report, Financial Results (Apr 15, 2009)

Filed April 15, 2009For Securities:ABT

Summary

This Form 8-K filing from Abbott Laboratories, dated April 15, 2009, announces the company's financial results for the first quarter of 2009. The report primarily focuses on the release of their earnings, highlighting the use of non-GAAP financial measures alongside GAAP. These non-GAAP measures, which exclude specified items like acquisition-related costs, cost reduction initiatives, and litigation settlements, are presented to offer investors a clearer view of ongoing business performance. Abbott's management emphasizes that these adjusted figures are intended to provide useful insights into the company's operational performance and are used internally for monitoring. However, the company cautions investors to consider these non-GAAP measures in conjunction with, and not as a replacement for, their standard GAAP financial statements, ensuring a comprehensive understanding of the company's financial health.

Key Highlights

  • 1Abbott Laboratories announced its first-quarter 2009 financial results on April 15, 2009.
  • 2The company utilized non-GAAP financial measures in its earnings announcement.
  • 3Non-GAAP measures exclude specified items such as acquisition-related costs, cost reduction initiatives, litigation settlements, product launch costs, acquired in-process R&D, and certain investment gains/losses.
  • 4Abbott's management believes these non-GAAP measures provide useful information for evaluating ongoing business performance.
  • 5These adjusted figures are also used internally by management to monitor business performance.
  • 6Investors are cautioned to consider non-GAAP measures in addition to, and not as a substitute for, GAAP measures.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce Abbott Laboratories' financial results for the first quarter of 2009 and to provide the accompanying press release.

Non-GAAP financial measures are financial metrics that exclude certain items from their GAAP (Generally Accepted Accounting Principles) counterparts. Abbott uses them to present what they believe is a clearer view of their ongoing business performance by excluding items that can be unusual or unpredictable, such as acquisition costs or litigation settlements.

No, Abbott explicitly cautions investors to consider these non-GAAP measures in addition to, and not as a substitute for, their financial measures prepared in accordance with GAAP. This means investors should review both GAAP and non-GAAP figures for a complete understanding.

The detailed financial results are provided in the press release furnished as Exhibit 99.1 to this 8-K filing.